MentionFoxEnsho Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-10-15.
Sell to companies like these? Paste your website and see 10 with a filed reason to buy this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-15 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Ensho Therapeutics, Inc.
Free to see. No signup.
We'll show it in your MentionFox inbox when Ensho Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Ensho Therapeutics, Inc. →Get the full cited report on Ensho Therapeutics, Inc.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ensho Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Ensho Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Ensho Therapeutics, Inc. See pricing
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $7.28M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Danielle Fry is named as Executive Officer on the Form D that Ensho Therapeutics, Inc. filed with the SEC on 15 October 2026, one of 7 people that filing names.
Arash Rassoulpour is named as Director on the Form D that Ensho Therapeutics, Inc. filed with the SEC on 15 October 2026, one of 7 people that filing names.
Carlos Solorzano is named as Director on the Form D that Ensho Therapeutics, Inc. filed with the SEC on 15 October 2026, one of 7 people that filing names.
Eric Pham is named as Director on the Form D that Ensho Therapeutics, Inc. filed with the SEC on 15 October 2026, one of 7 people that filing names.
Gerhard Hagn is named as Director on the Form D that Ensho Therapeutics, Inc. filed with the SEC on 15 October 2026, one of 7 people that filing names.
Neena Bitritto-Garg is named as Director on the Form D that Ensho Therapeutics, Inc. filed with the SEC on 15 October 2026, one of 7 people that filing names.
Tariq Kassum is named as Director on the Form D that Ensho Therapeutics, Inc. filed with the SEC on 15 October 2026, one of 7 people that filing names.
7 people named on the filing — 1 holding an executive role and 6 as directors only.
Named as of the 2026-10-15 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Ensho Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ensho Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Ensho Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Ensho Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Ensho Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/ensho-therapeutics-inc-form-d-000002